Clinical Trial Update: TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT [NA]

View source ↗

Summary

This clinical trial is evaluating a conditioning regimen of total body irradiation with fludarabine, busulfan, and melphalan followed by a secondary umbilical c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Hematopoietic Malignancy, Relapse/Recurrence | NA | Status: RECRUITING